Integra LifeSciences IART Specialty Surgery — Total Revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's specialty surgery — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Integra LifeSciences's specialty surgery — total revenues?
- Integra LifeSciences (IART) reported specialty surgery — total revenues of $283.14M in Q1 2026.
- What does specialty surgery — total revenues mean?
- This metric represents the total gross revenue generated by the Specialty Surgery business segment from the sale of medical devices and related services. It serves as a primary indicator of the segment's market demand and top-line growth performance within the broader medical technology portfolio.